{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T20:26:51Z","timestamp":1780691211822,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40272-020-00391-6","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T02:02:12Z","timestamp":1586224932000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacovigilance Reports Received from Children and Young People, and Development of Information to Aid Future Reporting from this Age Group"],"prefix":"10.1007","volume":"22","author":[{"given":"Nikita","family":"Bhoombla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitul","family":"Jadeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Hawcutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"issue":"9","key":"391_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2165\/11536510-000000000-00000","volume":"33","author":"DJ McLernon","year":"2010","unstructured":"McLernon DJ, Bond CM, Hannaford PC, Watson MC, Lee AJ, Hazell L, et al. Adverse drug reaction reporting in the UK. Drug Saf. 2010;33(9):775\u201388.","journal-title":"Drug Saf"},{"issue":"2","key":"391_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1365-2125.2006.02746.x","volume":"63","author":"A Blenkinsopp","year":"2007","unstructured":"Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148\u201356.","journal-title":"Br J Clin Pharmacol"},{"issue":"20","key":"391_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3310\/hta15200","volume":"15","author":"AJ Avery","year":"2011","unstructured":"Avery AJ, Anderson C, Bond C, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK \u2018Yellow Card Scheme\u2019: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15(20):49\u201372.","journal-title":"Health Technol Assess."},{"issue":"6","key":"391_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40264-014-0162-y","volume":"37","author":"F Margraff","year":"2014","unstructured":"Margraff F, Bertram D. Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf. 2014;37(6):409\u201319.","journal-title":"Drug Saf"},{"issue":"5","key":"391_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions. Drug Saf. 2006;29(5):385\u201396.","journal-title":"Drug Saf"},{"issue":"12","key":"391_CR6","doi-asserted-by":"publisher","first-page":"e50127","DOI":"10.1371\/journal.pone.0050127","volume":"7","author":"RM Gallagher","year":"2012","unstructured":"Gallagher RM, Mason JR, Bird KA, Kirkham JJ, Peak M, Williamson PR, et al. Adverse drug reactions causing admission to a paediatric hospital. PLoS ONE. 2012;7(12):e50127.","journal-title":"PLoS ONE"},{"issue":"1","key":"391_CR7","first-page":"237","volume":"11","author":"S Thiesen","year":"2013","unstructured":"Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children\u2014a prospective observational cohort study of 6,601 admissions. BioMed Cent Med. 2013;11(1):237.","journal-title":"BioMed Cent Med"},{"issue":"3","key":"391_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2125.2011.04113.x","volume":"73","author":"DB Hawcutt","year":"2012","unstructured":"Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M. Reported paediatric adverse drug reactions in the UK 2000\u20132009. Br J Clin Pharmacol. 2012;73(3):437\u201346.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"391_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/pds.1121","volume":"14","author":"E Kimland","year":"2005","unstructured":"Kimland E, Rane A, Ufer M, Panagiotidis G. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf. 2005;14(7):493\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"391_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1542\/peds.2005-2429","volume":"118","author":"J Le","year":"2006","unstructured":"Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006;118(2):555\u201362.","journal-title":"Pediatrics"},{"issue":"4","key":"391_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/11319100-000000000-00000","volume":"33","author":"L Aagaard","year":"2010","unstructured":"Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark. Drug Saf. 2010;33(4):327\u201339.","journal-title":"Drug Saf"},{"issue":"10","key":"391_CR12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0895-4356(00)00190-6","volume":"53","author":"F Morales-Olivas","year":"2000","unstructured":"Morales-Olivas F, Mart\u0131nez-Mir I, Ferrer J, Rubio E, Palop V. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol. 2000;53(10):1076\u201380.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"391_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4103\/0976-500X.85957","volume":"2","author":"R Priyadharsini","year":"2011","unstructured":"Priyadharsini R, Surendiran A, Adithan C, Sreenivasan S, Sahoo FK. A study of adverse drug reactions in pediatric patients. J Pharmacol Pharmacother. 2011;2(4):277.","journal-title":"J Pharmacol Pharmacother"},{"issue":"10","key":"391_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/14740338.2016.1221921","volume":"15","author":"KO Cliff-Eribo","year":"2016","unstructured":"Cliff-Eribo KO, Sammons H, Choonara I. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Expert Opin Drug Saf. 2016;15(10):1321\u20138.","journal-title":"Expert Opin Drug Saf"},{"key":"391_CR15","doi-asserted-by":"crossref","unstructured":"Royal College of Paediatrics and Child Health. The State of Child Health Report 2017 Royal College of Paediatrics and Child Health 2017. https:\/\/stateofchildhealth.rcpch.ac.uk\/. Accessed 3 Apr 2020.","DOI":"10.12968\/cypn.2017.6.35"},{"issue":"5","key":"391_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1369-7625.2012.00795.x","volume":"17","author":"J Brett","year":"2014","unstructured":"Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17(5):637\u201350.","journal-title":"Health Expect"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-020-00391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-020-00391-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-020-00391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T16:14:22Z","timestamp":1696004062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-020-00391-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1007\/s40272-020-00391-6","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"7 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"There were no financial relationships with any organisations that might have an interest in the submitted work in the previous 3\u00a0years, and no other relationships or activities that could appear to have influenced the submitted work. There was no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}